Afuresertib Active Not Recruiting Phase 2 Trials for Platinum-resistant Ovarian Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04374630Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian